Cinqair is a prescription medication used to treat severe asthma in adults. It is specifically indicated for patients who have not had success with other asthma medications, such as inhaled corticosteroids and long-acting beta agonists. Cinqair works by targeting a specific type of white blood cell called eosinophils, which are known to play a role in inflammation and asthma symptoms.

This medication is administered as an intravenous infusion once every 4 weeks in a healthcare setting. The infusion process typically takes about 1 hour, and patients are monitored closely during and after the infusion to ensure safety and efficacy.

Cinqair has been shown to reduce asthma exacerbations and improve lung function in clinical trials. It is important to note that this medication is not a rescue inhaler and should not be used to treat sudden asthma attacks. Patients should continue to use their rescue inhaler as prescribed by their healthcare provider.

As with any medication, Cinqair may cause side effects in some patients. Common side effects include headache, back pain, fatigue, and muscle pain. More serious side effects, such as allergic reactions or anaphylaxis, are rare but can occur. It is important for patients to discuss any concerns or potential side effects with their healthcare provider.

Overall, Cinqair can be an effective treatment option for adults with severe asthma who have not responded well to other medications. It is important for patients to work closely with their healthcare provider to determine if Cinqair is the right choice for their asthma management plan.